Subcutaneous TNF inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Subcutaneous TNF inhibitor, covering 2026-02-05 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM) [Phase 4]